Glenmark receives Orphan Drug Designation for GBR 1342 EP News Bureau Sep 17, 2019 The drug is indicated for the treatment of multiple myeloma Glenmark Pharmaceuticals (Glenmark), announced that the US Food and…
Global multiple myeloma treatment market value to approach $9 billion by 2021: GBI Research Sanjiv Das Aug 21, 2015 This will be driven primarily by rising multiple myeloma prevalence as a result of an aging population The global multiple…
